Investor List:

Top Pharmaceuticals Series B Investors in London (14)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Alessandro Luciano, Vice President at Insight Partners
Alessandro Luciano
Insight Partners·Vice President
Sweet spot: $25.0M
Range: $10.0M - $350.0M
Investors in London
Photo of Pablo Lubroth, Investor at Hummingbird Ventures
Pablo Lubroth
Sweet spot: $2.8M
Range: $500K - $5.0M
Investors in London, Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in London (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in DeepTech (Series B), Investors in DeepTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Therapeutics (Series A), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in DeepTech (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Series B), Investors in BioTech (Pre-seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
Photo of Shahzad Malik, General Partner at Advent Life Sciences
Shahzad Malik
Advent Life Sciences·General Partner
Sweet spot: $1M
Range: $25K - $5.0M
Investors in London
Photo of Rajesh Chopra, Venture Partner at ATP (Apple Tree Partners)
Rajesh Chopra
ATP (Apple Tree Partners)·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United Kingdom, Investors in London
Photo of Laurence Barker, Partner at SV Health Investors
Laurence Barker
Sweet spot: $1.5M
Range: $100K - $1.5M
Investors in London
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in London (Other Lists)
Photo of Jason Foster, Venture Partner at Hambro Perks
Jason Foster
Hambro Perks·Venture Partner
Sweet spot: $7.5M
Range: $5.0M - $10.0M
Investors in London
Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in Marketplaces (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Manufacturing (Series B), Investors in Pharmaceuticals (Series B), Investors in Manufacturing (Series A), Investors in Manufacturing (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Marketplaces (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Marketplaces (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in Manufacturing (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Marketplaces (Series A), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Marketplaces (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in London (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Marketplaces (Pre-seed), Investors in Health IT (Pre-seed), Investors in Marketplaces (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Marketplaces (Seed)
Photo of Jeanne Bolger, Venture Partner at Seroba Life Sciences
Jeanne Bolger
Seroba Life Sciences·Venture Partner
Sweet spot: $6.0M
Range: $5.0M - $7.0M
Investors in London
Photo of Fiona MacLaughlin, Principal at Johnson & Johnson Innovation
Fiona MacLaughlin
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London, Investors in United Kingdom